Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2001030391) PHARMACEUTICAL COMPOSITION CONTAINING MIDAZOLAM
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2001/030391 International Application No.: PCT/IB2000/001525
Publication Date: 03.05.2001 International Filing Date: 24.10.2000
Chapter 2 Demand Filed: 14.05.2001
IPC:
A61K 9/00 (2006.01) ,A61K 31/5517 (2006.01) ,A61K 47/48 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
55
having seven-membered rings, e.g. azelastine, pentylenetetrazole
551
having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep
5513
1,4-Benzodiazepines, e.g. diazepam
5517
condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
48
the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
Applicants:
PENKLER, Lawrence, John [ZA/ZA]; ZA (UsOnly)
FARMARC NEDERLAND BV [NL/NL]; Citco Trust International Management (T.I.M.) BV World Trade Centre Tower B, 17th Floor Strawinskylaan NL-1725 100 JE Amsterdam, NL (AllExceptUS)
Inventors:
PENKLER, Lawrence, John; ZA
Agent:
KEMP, Mark; Spoor and Fisher PO Box 41312 2024 Craighall, ZA
Priority Data:
99/675627.10.1999ZA
Title (EN) PHARMACEUTICAL COMPOSITION CONTAINING MIDAZOLAM
(FR) COMPOSITION PHARMACEUTIQUE CONTENANT DU MIDAZOLAM
Abstract:
(EN) A pharmaceutical composition for transmucosal delivery comprises an aqueous solution of an inclusion complex of midazolam and a water-soluble substituted beta-cyclodextrin. The solution contains from 2 to 20 mg/ml of midazolam and has a pH of from 4 to 7.
(FR) Une composition pharmaceutique destinée à l'administration par voie transmucosale comprend une solution aqueuse d'un composé d'inclusion de midazolam et d'une bêta-cyclodextrine substituée soluble dans l'eau. La solution contient entre 2 et 20 mg/ml de midazolam et son pH se situe entre 4 et 7.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)